A Phase II Randomized Controlled Trial: Definitive Concurrent Chemoradiotherapy with Docetaxel Plus Cisplatin versus 5-Fluorouracil plus Cisplatin in Patients with Oesophageal Squamous Cell Carcinoma

Purpose: To evaluate the efficacy and toxicity of definitive concurrent chemoradiotherapy (CCRT) with docetaxel plus cisplatin (DP regimen) versus 5-fluorouracil plus cisplatin (PF regimen) in patients with oesophageal squamous cell carcinoma (ESCC). Patients and Methods: In this phase II randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yujia, Zhang, Wenwen, Li, Qiaoqiao, Li, Qiwen, Qiu, Bo, Liu, Hui, Liu, Mengzhong, Hu, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688918/
https://www.ncbi.nlm.nih.gov/pubmed/29151952
http://dx.doi.org/10.7150/jca.20053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688918/
https://www.ncbi.nlm.nih.gov/pubmed/29151952
http://dx.doi.org/10.7150/jca.20053

Ejemplares similares